A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 88
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : PRSP
Long Form : penicillin-resistant S. pneumoniae
No. Year Title Co-occurring Abbreviation
2022 Molecular Characterization of Penicillin-Binding Protein2x, 2b and 1a of Streptococcus pneumoniae Causing Invasive Pneumococcal Diseases in China: A Multicenter Study. BLAs, CSF, IPDs, PBPs, PEN
2022 Penicillin- and third-generation cephalosporin-resistant strains of Streptococcus pneumoniae meningitis: Case report and literature review. CTRX, LVFX, RFP, VCM
2019 Efficacy of Delafloxacin versus Moxifloxacin against Bacterial Respiratory Pathogens in Adults with Community-Acquired Bacterial Pneumonia (CABP): Microbiology Results from the Delafloxacin Phase 3 CABP Trial. CABP, CAP, i.v, MITT, MRSA, MSSA
2018 Analysis of amino acid motif of penicillin-binding proteins 1a, 2b, and 2x in invasive Streptococcus pneumoniae nonsusceptible to penicillin isolated from pediatric patients in Casablanca, Morocco. PSSP
2017 Genome Evolution to Penicillin Resistance in Serotype 3 Streptococcus pneumoniae by Capsular Switching. ---
2017 Serotype distribution of Streptococcus pneumoniae isolated from adult respiratory tract infections in nationwide Japanese surveillances from 2006 to 2014. PCVs
2017 [Bacteriological Analysis of Pneumococcus Detected from the Sputum of Hospitalized Children]. IPD, PISP, PSSP
2016 Molecular characteristics of penicillin-binding protein 2b, 2x and 1a sequences in Streptococcus pneumoniae isolates causing invasive diseases among children in Northeast China. IPD, PBPs, PNSP
2015 Nationwide survey of Streptococcus pneumoniae drug resistance in the pediatric field in Japan. PISP
10  2015 Penicillin-Resistant trend of Streptococcus pneumoniae in Asia: A systematic review. ---
11  2014 Changes in pneumococcal serotypes and antimicrobial resistance after introduction of the 13-valent conjugate vaccine in the United States. MDR
12  2014 Molecular chaperones (TrxA, SUMO, Intein, and GST) mediating expression, purification, and antimicrobial activity assays of plectasin in Escherichia coli. AMP, GST, MRSA, PS, SUMO, TrxA, VRE
13  2014 Serotype distribution and susceptibility to penicillin and erythromycin among noninvasive or colonization isolates of Streptococcus pneumoniae in northern Japan: a cross-sectional study in the pre-PCV7 routine immunization period. EM, MIC, PCR
14  2014 Twelve-year survey (2001-2012) of the antimicrobial susceptibility of Streptococcus pneumoniae isolates from otorhinolaryngology clinics in Miyagi Prefecture, Japan. MICs
15  2014 [Surveillance report of drug-resistant bacteria from 2007 to 2012 in Saga Prefecture, Japan (the second report)]. BLNAR, ESBL, MBL, MDRP, MRSA, PISP
16  2013 Nationwide survey of the development of drug-resistant pathogens in the pediatric field in 2007 and 2010: drug sensitivity of Streptococcus pneumoniae in Japan (second report). MIC, PISP, PSSP
17  2013 [Antibacterial activity for clinical isolates from pediatric patients of clavulanic acid/amoxicillin (1: 14) -outcomes of special drug use investigation on antibacterial activity (annual changes)]. BLNAR, BLNAS, PISP, PSSP
18  2012 Determination of phenotypes and pneumococcal surface protein A family types of Streptococcus pneumoniae from Malaysian healthy children. MDRSP, PCV, PspA
19  2012 In vivo antibacterial activity of chinfloxacin, a new fluoroquinolone antibiotic. MRSA, PISP, PSSP, VRE, VSE
20  2012 [Antimicrobial susceptibility of community-acquired respiratory tract pathogens isolated from adults in China during 2009 and 2010]. PISP, PSSP
21  2011 Nasopharyngeal Streptococcus pneumoniae carriage in Japanese children attending day-care centers. DCCs, PBP, PFGE, PISP
22  2011 [Distributions and spreads of antimicrobial drug-resistant microorganisms in Saga prefecture]. BLNAR, ESBL, MBL, MDRP, MRSA, PFGE, PISP
23  2010 Antibiotic susceptibility of respiratory pathogens recently isolated in Italy: focus on cefditoren. CARTI
24  2010 In vitro antimicrobial activity of cefditoren and other oral antibiotics against Streptococcus pneumoniae, isolated from children with community acquired respiratory tract infections. ---
25  2010 [Clinical characteristics and antimicrobial resistance of invasive pneumococcal disease in children]. CSF, IPD, PISP, SP
26  2010 [Evaluation of the safety and efficacy of cefditoren pivoxil fine granules for pediatric use in pediatric patients with acute otitis media]. BLNAR, PISP
27  2010 [Resistance study of community respiratory pathogens isolated in China from 2005 to 2007]. PISP, PNSSP, PSSP, SXT
28  2009 Nationwide survey of the development of drug-resistant pathogens in the pediatric field: drug sensitivity of Streptococcus pneumoniae in Japan. PISP, PSSP
29  2009 [Changes in the drug resistance of Haemophilus influenzae and Streptococcus pneumoniae isolated between 1997 and 2006]. BLNAR, BLNAS, H. influenzae, PISP, PSSP, S. pneumoniae
30  2008 Clinical bacteriology and immunology in acute otitis media in children. AOM, NTHi, PCPs, PspA
31  2008 Increasing prevalence of antimicrobial resistance in Streptococcus pneumoniae in Kuwait: implications for therapy. CSF, MIC
32  2008 Serotype distribution and penicillin resistance of Streptococcus pneumoniae isolates from middle ear fluids of pediatric patients with acute otitis media in Japan. PCV
33  2008 The first nationwide surveillance of bacterial respiratory pathogens conducted by the Japanese Society of Chemotherapy. Part 1: a general view of antibacterial susceptibility. BLNAR, BLPAR, CLSI, JSC, MRSA, PISP, RTIs
34  2008 Tracking resistance among bacterial respiratory tract pathogens: summary of findings of the TRUST Surveillance Initiative, 2001-2005. TMP-SMX, TRUST
35  2007 Alterations of pbp1a, pbp2b, and pbp2x in Streptococcus pneumoniae isolates from children with otolaryngological infectious disease in the Sapporo district of Japan. PBP, PCR
36  2007 Clinical and bacteriological evaluation of the efficacy of piperacillin in children with pneumonia. MIC, PISP, PSSP
37  2007 Differences between ceftriaxone and cefotaxime: microbiological inconsistencies. MIC
38  2007 Emergence and trends of penicillin non-susceptible Streptococcus pneumoniae in Saudi Arabia and Kuwait - perspective and outstanding issues. PBPs
39  2006 Pharmacokinetically enhanced amoxicillin/clavulanate (2,000/125 mg) in acute bacterial rhinosinusitis caused by Streptococcus pneumoniae, including penicillin-resistant strains. ABRS, MICs
40  2006 Risk factors and clinical outcomes of penicillin resistant S. pneumoniae community-acquired pneumonia in Khon Kaen, Thailand. CAP
41  2006 [Analysis of the macrolide resistance gene in penicillin-resistant Streptococcus pneumoniae]. PSSP, S. pneumoniae
42  2006 [Sensitivity surveillance of Streptococcus pneumoniae isolates for several antibiotics in Gifu prefecture (2004)]. PBP, PSSP
43  2005 Antimicrobial activities of tosufloxacin against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella branhamella catarrhalis isolated from otolaryngological infectious diseases. BLNAR, MIC, TFLX
44  2005 In vitro activity of beta-lactams, macrolides, telithromycin, and fluoroquinolones against clinical isolates of Streptococcus pneumoniae: correlation between drug resistance and genetic characteristics. g-PRSP, MICs, PISP, PSSP
45  2005 In vivo efficacies and pharmacokinetics of DX-619, a novel des-fluoro(6) quinolone, against Streptococcus pneumoniae in a mouse lung infection model. AUC, PSSP
46  2005 [Surveillance of susceptibility of clinical isolates to cefpodoxime between 2000 and 2003]. BLNAR, ESBL
47  2005 [Two cases of Bartholin's gland abscesses caused by Streptococcus pneumoniae and Haemophilus influenzae]. BLNAR, CFDN, CFTM-PI
48  2004 Pharmacodynamics and bactericidal activity of gatifloxacin in experimental pneumonia caused by penicillin-resistant Streptococcus pneumoniae. CPFX, GFLX, LVFX
49  2004 [Antibacterial activity of oral Cephems against various clinically isolated strains]. BLNAR, BLNAS, CCL, CDTR, CFPN, CFTM, PISP, PSSP
50  2004 [Antimicrobial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Pseudomonas aeruginosa isolated in major hospitals in Nagano prefecture]. BLNAR, BLPAR, CTRX, MIC, PISP, PSSP
51  2004 [Isolation-frequency and antibiotic susceptibility of Streptococcus pneumoniae, Haemophilus influenzae, and Pseudomonas aeruginosa isolated in regional core hospitals in the Nagaoka district of Niigata Prefecture (changes for 3 years)]. MEPM, PISP, PSSP
52  2004 [Resistance surveillance of common community respiratory pathogens isolated in China, 2002 - 2003]. MSSA, PISP
53  2003 Current status of bacterial resistance in the otolaryngology field: results from the Second Nationwide Survey in Japan. BLNAR, BLNASe, MRSA, PISP, PSSP, VCM
54  2003 In vivo efficacy of a new quinolone, DQ-113, against Streptococcus pneumoniae in a mouse model. AUC, PSSP
55  2003 Oral pharmacokinetically enhanced co-amoxiclav 2000/125 mg, twice daily, compared with co-amoxiclav 875/125 mg, three times daily, in the treatment of community-acquired pneumonia in European adults. CAP, PP, TD
56  2003 Pharmacokinetics and efficacy of linezolid in a gerbil model of Streptococcus pneumoniae-induced acute otitis media. AOM, PSSP
57  2003 [Alteration of antibacterial activity of tosufloxacin and various antibacterial agents against Streptococcus pneumoniae]. AZM, CFDN, CFTM, CPDX, CPFX, GFLX, LVFX, MICs, PISP, PSSP, SPFX, TFLX
58  2003 [Antibacterial activity of panipenem against clinical isolates in 2000 and 2001]. BLNAR, ESBL, IPM, MEPM, PAPM, PISP
59  2003 [Antimicrobial susceptibility of Streptococcus pneumoniae and Haemophilus influenzae isolated in major hospitals in Nagano Prefecture]. BLNAR, CFPM, CTX, MIC, PISP, PSSP
60  2003 [Post-marketing surveillance of antibacterial activities of cefozopran against various clinical isolates--I. Gram-positive bacteria]. CFPM, CPR, CZOP, MRSA, MRSE, MSSA, MSSE, PISP, PSSP
61  2003 [Report of questionnaire survey for methicillin-resistant Staphylococcus aureus and penisillin-resistant Streptococcus pneumoniae between 1998 and 2000 in the Kinki district]. ABK, MRSA, ST, TEIC, VCM
62  2002 Antimicrobial activities of cefditoren against respiratory pathogens isolated from children in Japan. CDTR, PISP
63  2002 Comparative in vitro activity of carbapenem antibiotics against respiratory pathogens isolated in recent years. MRSA, MSSA, PSSP
64  2002 Comparative in-vitro activity of carbapenem antibiotics against respiratory pathogens isolated between 1999 and 2000. MRSA, MSSA, PSSP
65  2002 Rapidly increasing prevalence of penicillin-resistant Streptococcus pneumoniae in middle Tennessee: a 10-year clinical and molecular analysis. ---
66  2002 [Post-marketing surveillance of antibacterial activities of cefozopran against various clinical isolates--I. Gram-positive bacteria]. CFPM, CPR, CTM, CZOP, MRSA, MRSE, MSSA, MSSE, PISP, PSSP
67  2002 [Resistance to antimicrobiotics and mutation of PBPs in Streptococcus pneumoniae isolated from Kinki region of Japan]. MIC, NCCLS, PCG, PISP, PSSP
68  2002 [Surveillance of bacterial resistance in China (1998-1999)]. CAI, HI, MDR, MRSA
69  2001 Penicillin-resistant Streptococcus pneumoniae endocarditis: a case report and review. ---
70  2001 [Nationwide sensitivity surveillance of various antibiotic activities against bacteria isolated from patients with severe infections]. MRSA
71  2001 [The frequency of Streptococcus pneumoniae strains and sensitivity surveillance for several antibiotics in Gifu Prefecture]. CAM, CDTR, CLDM, CPFX, IPM, LVFX, MEPM, MINO, PAPM, PISP, PSSP, SPFX, TFLX
72  2000 Efficacy of a novel tetracycline derivative, glycylcycline, against penicillin-resistant Streptococcus pneumoniae in a mouse model of pneumonia. ---
73  2000 [Drug-resistant bacteria of current topics and their resistance mechanisms--PRSP and BLNAR]. BLNAR, PBPs
74  2000 [Identification of bacterial strain at each episode of recurrent acute otitis media]. BLNAR, PISP, PSSP, RAOM
75  2000 [Investigation of the antibacterial activity of faropenem against Streptococcus pneumoniae]. MIC90, PSSP
76  1999 In vitro antibacterial activity of LJC 11,036, an active metabolite of L-084, a new oral carbapenem antibiotic with potent antipneumococcal activity. ---
77  1999 In-vitro activity of 29 antimicrobial agents against penicillin-resistant and -intermediate isolates of Streptococcus pneumoniae. PISP
78  1999 Molecular analysis of the genetic variation among penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae serotypes in Canada. PSSP
79  1999 [In vitro and in vivo activities of cefpodoxime proxetil against penicillin-resistant Streptococcus pneumoniae]. CDTR-PI, CFDN, CPDX-PR, FRPM, PISP, PSSP
80  1998 Clonal relationships among high-level penicillin-resistant Streptococcus pneumoniae in the United States. PFGE
81  1998 [Identification of penicillin-resistant Streptococcus pneumoniae in nasopharynx of patient with acute otitis media by PCR]. AOM, PCR, PSSP
82  1998 [Occurrences of penicillin-binding protein 2B gene in clinically isolated penicillin-resistant Streptococcus pneumoniae]. PBP2B, S. pneumoniae
83  1997 Determination of penicillin susceptibility of Streptococcus pneumoniae using the polymerase chain reaction. MIC, PBP, PCR, PSSP, SP
84  1997 Evaluation of the E-test for routine testing of the susceptibility of Streptococcus pneumoniae to benzylpenicillin, amoxicillin and cefotaxime. ---
85  1997 Surveillance for penicillin-nonsusceptible Streptococcus pneumoniae--New York City, 1995. HIV, MIC, NYCDOH, PNSP
86  1997 [Prevalence of antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in a children's hospital]. ---
87  1995 Clinical isolates and nasopharyngeal carriage of antibiotic-resistant Streptococcus pneumoniae in Hospital for Infectious Diseases, Sofia, Bulgaria, 1991-1993. ---
88  1995 [Serotypes and antimicrobial susceptibility of Streptococcus pneumoniae from clinical specimens]. CCL, CEZ, CLDM, CTM, CTX, DIZD, EM, IPM, K-B, MD, MIC, MINO, OFLX, PISP, PSSP